EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Yixiao Formula Suppresses Myocardial Fibrosis Through UpregulatingmiR‐133a and Downregulating TGF‐ β /Smads Signal Molecules

Qiyao Zhao iD, Yalu Wen, Honghui Wu, Jiaoyue Li iD, Yunpeng Luo, Ping Li, Ye Zhang, Chaoyue Hu, Jukai Huang, Li Zhang, Xiaohui Yang iD

Journal of Diabetes Research · 2026

DOI: 10.1155/jdr/5533249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Qiyao Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Endocrine (II), Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn. Hauptthemen laut MEDLINE: MicroRNAs, Drugs, Chinese Herbal, Transforming Growth Factor beta, Diabetic Cardiomyopathies. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing University of Chinese Medicine, Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Yixiao formula (YXF), a traditional Chinese herbal medicine, has demonstrated clinical efficacy in alleviating symptoms of diabetic cardiomyopathy (DCM). The therapeutic mechanism underlying YXF′s effects on DCM remains poorly understood. Myocardial fibrosis is a key pathogenic mechanism in DCM, and previous studies have indicated that miR‐133a may be involved in its progression. Given that the TGF‐ β /Smads signaling pathway is a well‐established mediator of myocardial fibrosis, investigating the mechanistic role of YXF through miR‐133a and the TGF‐ β /Smads pathway warrants further exploration.

Objective

The main objective of this study is to investigate the potential contribution of the TGF‐ β /Smads pathway to the effects of YXF, as well as the role of miR133a, through in vivo DCM models and in vitro experiments. Materials and Methods Spontaneously diabetic KKAy mice were used to establish a DCM model by continuous high‐fat feeding, with C57BL/6 mice as controls. Echocardiography, body weight, and blood glucose data were collected every 4 weeks to examine the effects of YXF on blood glucose levels and changes in cardiac function and structure in DCM mice. Immunohistochemistry, RT‐qPCR, and western blot were used to detect the expression levels of the TGF‐ β /Smads pathway. Additionally, the potential molecular mechanism of YXF in mouse cardiac fibroblasts (MCFs) was investigated by knocking down miR‐133a.

Results

YXF improved fasting blood glucose levels in DCM mice, promoted cardiac diastolic function, upregulated miR133a, and inhibited the expression of the TGF‐ β /Smads pathway. Furthermore, when miR133a inhibitors were transfected under YXF intervention, we found that YXF′s inhibitory effect on the TGF‐ β /Smads pathway was weakened.

Conclusion

Through this study, we found that YXF can increase miR133a and inhibit the expression of the TGF‐ β /Smads pathway, thereby inhibiting myocardial fibrosis and exerting a protective effect on DCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrugs, Chinese HerbalTransforming Growth Factor betaDiabetic CardiomyopathiesMyocardiumSmad ProteinsAnimalsSignal TransductionMiceFibrosisUp-RegulationMice, Inbred C57BLMaleDown-Regulation

Stichwörter der Autor:innen

TGF-β/Smadscardiac fibroblastsdiabetic cardiomyopathymiR133atraditional Chinese medicine

Substanzen

MicroRNAsDrugs, Chinese HerbalMirn133 microRNA, mouseTransforming Growth Factor betaSmad Proteins

Autor:innen und Institutionen

  • Department of Nephrology and Endocrine (II), Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn.
  • Specialized Department for the Integrated Treatment of Diabetes and Obesity With Traditional Chinese and Western Medicine, Tongde Hospital of Zhejiang Province, Hangzhou, China, zjtongde.com.
  • Department of Respiratory Medicine, Beijing Hepingli Hospital, Beijing, China.
  • Department of Internal Medicine, Jingkai District, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn.
  • Department of Scientific Research, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn.

ORCID-Profile: Qiyao Zhao, Jiaoyue Li, Xiaohui Yang

Förderung

  • Beijing University of Chinese Medicine
  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, Q., Wen, Y., Wu, H., Li, J., Luo, Y., Li, P., Zhang, Y., Hu, C., Huang, J., Zhang, L., & Yang, X. (2026). Yixiao Formula Suppresses Myocardial Fibrosis Through UpregulatingmiR‐133a and Downregulating TGF‐ β /Smads Signal Molecules. Journal of Diabetes Research. https://doi.org/10.1155/jdr/5533249

Vancouver

Zhao Q, Wen Y, Wu H, Li J, Luo Y, Li P, et al. Yixiao Formula Suppresses Myocardial Fibrosis Through UpregulatingmiR‐133a and Downregulating TGF‐ β /Smads Signal Molecules. Journal of Diabetes Research. 2026. doi:10.1155/jdr/5533249

BibTeX
@article{Zhao2026,
  author = {Zhao, Qiyao and Wen, Yalu and Wu, Honghui and Li, Jiaoyue and Luo, Yunpeng and Li, Ping and Zhang, Ye and Hu, Chaoyue and Huang, Jukai and Zhang, Li and Yang, Xiaohui},
  title = {Yixiao Formula Suppresses Myocardial Fibrosis Through UpregulatingmiR‐133a and Downregulating TGF‐ β /Smads Signal Molecules},
  journal = {Journal of Diabetes Research},
  year = {2026},
  doi = {10.1155/jdr/5533249}
}
Kostenlos starten →